US Inflation Accelerates to 38 in April Hitting Highest Level in Nearly a Year Political Risk and Investor Sentiment Trumps 230m Claim Raises Governance Concerns Spencer Pratts Social Media Strategy Could Reshape Political Campaigning But Can It Win LA Mayoral Race How Inflation Erodes Savings The Interest Rate Needed to Beat Rising Prices Family Resort Sector Shows Strength as Travel Demand Drives Luxury AllInclusive Expansion in 2026 ADP Reports Private Payrolls Rose 109000 in April Exceeding Expectations Oklo Inc OKLO Q1 2026 Earnings EPS Surpasses Estimates Amid No Revenue Reported NG Q1 2026 Earnings EPS Beat Amid Ongoing Development Progress QURE Q1 2026 Earnings Narrower Loss Than Expected but Stock Declines on Lack of Revenue Preformed Line Products Company PLPC Q1 2026 Earnings Strong EPS Beat Drives PostReport Rally ITRG Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction AZZ Inc AZZ Q1 2026 Earnings EPS Beat Amid Solid Execution Revenue Details Not Disclosed Five Point Holdings FPH Edges Lower as Stock Tests Key Support at 468 John Hancock Premium Dividend Fund PDT Edges Higher Amid Steady Income Focus MIAX Slides 23 as Miami International Holdings Holds Above Key Support MBVIW Warrants Hold Steady at 040 as Merger Timeline Watchers Await Catalyst Sachem Capital Corp Notes SCCE Slips Fractionally as Bond Market Consolidates BCG Report Reveals 5000 UltraRich Hold Over a Quarter of Germanys Financial Wealth Jefferies Financial Group Inc JEF Q1 2026 Earnings EPS Misses Estimates as Stock Slips Copel ELPC Slips 127 as Technical Levels Come into Focus GLRE Q1 2026 Earnings Strong Profitability Drives Positive Market Response NTIC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment MAPS Q1 2026 Earnings EPS Miss Weighs on Shares Despite Narrow Profit First Industrial Realty Trust FR Q1 2026 Earnings Massive EPS Surge Overshadowed by Stock Decline MTD Q1 2026 Earnings EPS Surpasses Estimates Despite Limited Revenue Disclosure Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path RZB Q1 2026 Earnings Strong EPS Surprise Signals Solid Underwriting Performance